Keros Therapeutics

+$0.74 (+2.05%) Today
$0.00 (0.00%) As of 8:00 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KROS and other ETFs, options, and stocks.

About KROS

Keros Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with unmet medical need.

CEO
Jasbir S. Seehra
Employees
60
Headquarters
Lexington, Massachusetts
Founded
2015

KROS Key Statistics

Market cap
886.17M
Price-Earnings ratio
—
Dividend yield
—
Average volume
264.85K
High today
$38.25
Low today
$35.52
Open price
$36.94
Volume
199.62K
52 Week high
$68.29
52 Week low
$28.50

KROS Earnings

-$1.01
-$0.67
-$0.34
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure